Figure 1. Kaplan-Meier plots depicting prostate cancer (PCa) progression – free survival according to A) tumor upgrading (ISUP grade group >3); B) the 2012 Briganti nomogram score (≤6% vs. >6%), and C) line plot illustrating the distribution of the 2012 Briganti nomogram score stratified by tumor upgrading and cancer progression in the overall cohort of 147 EAU intermediate-risk patients presenting with PSA <10 ng/mL, clinical stage up to cT2b, and ISUP grade group 3 and treated with robot assisted radical prostatectomy eventually associated with extended pelvic lymph node invasion.